Matsui Hiroko, Ikeda Kazuo, Nakatani Kazuki, Sakabe Masahide, Yamagishi Toshiyuki, Nakanishi Toshio, Nakajima Yuji
Department of Anatomy, Graduate School of Medicine, Osaka City University, Abenoku, Osaka, Japan.
Dev Dyn. 2005 Aug;233(4):1419-29. doi: 10.1002/dvdy.20477.
During early cardiogenesis, endoderm-derived bone morphogenetic protein (BMP) induces the expression of both heart-specific transcription factors and sarcomeric proteins. However, BMP antagonists do not inhibit the expression of the "initial heart alpha-actin"--smooth muscle alpha-actin (SMA)--which is first expressed in the anterior lateral mesoderm and then recruited into the initial myofibrils (Nakajima et al. [2002] Dev. Biol. 245:291-303). Therefore, mechanisms that regulate the expression of SMA in the heart-forming mesoderm are not well-understood. Regional explantation experiments using chick blastoderm showed that the posterolateral region of the epiblast differentiated into cardiomyocytes. Posterior epiblast cultured with or without the associated hypoblast showed that interaction between the tissues of these two germ layers at the early pregastrula stage (stages X-XI) was a prerequisite for the expression of SMA. Posterior epiblast that is cultured without hypoblast could also be induced to express SMA if TGF-beta or activin was added to the culture medium. However, neither neutralizing antibodies against TGF-betas nor follistatin perturbed the expression of SMA in cultured blastoderm. Adding BMP to the cultured blastoderm inhibited the expression of SMA, whereas BMP antagonists, such as chordin, were able to induce the expression of SMA in cultured posterior epiblast. Furthermore, adding lefty-1, a nodal antagonist, to the blastoderm inhibited the expression of SMA, and nodal plus BMP antagonist up-regulated the expression of SMA in cultured posterior epiblast. Results indicate that the interaction between the tissues of the posterior epiblast and hypoblast is necessary to initiate the expression of SMA during early cardiogenesis and that nodal and BMP antagonist may play an important role in the regulation of SMA expression.
在心脏发生早期,内胚层来源的骨形态发生蛋白(BMP)诱导心脏特异性转录因子和肌节蛋白的表达。然而,BMP拮抗剂并不抑制“初始心脏α-肌动蛋白”——平滑肌α-肌动蛋白(SMA)的表达,该蛋白首先在前外侧中胚层表达,然后被募集到初始肌原纤维中(中岛等人[2002]《发育生物学》245:291 - 303)。因此,调节心脏形成中胚层中SMA表达的机制尚未完全清楚。使用鸡胚盘进行的区域外植体实验表明,上胚层的后外侧区域分化为心肌细胞。与相关下胚层一起或不一起培养的后上胚层表明,这两个胚层组织在原肠胚形成前期(X - XI期)的相互作用是SMA表达的前提条件。如果在培养基中添加TGF-β或激活素,未与下胚层一起培养的后上胚层也可被诱导表达SMA。然而,针对TGF-β的中和抗体或卵泡抑素均未干扰培养的胚盘中SMA的表达。向培养的胚盘中添加BMP会抑制SMA的表达,而BMP拮抗剂,如脊索蛋白,能够在培养的后上胚层中诱导SMA的表达。此外,向胚盘中添加节点拮抗剂左y-1会抑制SMA的表达,而节点加BMP拮抗剂会上调培养的后上胚层中SMA的表达。结果表明,后上胚层和下胚层组织之间的相互作用对于心脏发生早期启动SMA的表达是必要的,并且节点和BMP拮抗剂可能在SMA表达的调节中起重要作用。